Illuminating Personalized Medicine
Porphyrin-based Aggregation-induced Emission Generating Molecules for Continuous Multi-Metabolite Monitoring
Personialized Medicine Study
In this project, a new sensor technology is being developed to improve the monitoring of multiple metabolites. Special molecules with aggregation-induced emission, known as AIEgens, are utilized, which emit particularly bright luminescence upon aggregation. These AIEgens are designed to emit light in different spectral regions, enabling the simultaneous measurement of various metabolites such as glucose, lactate, and ketones. Integrated into a biocompatible matrix and applied to the tip of an optical sensor, which is incorporated into a wearable device, this minimally invasive system allows for continuous monitoring of metabolism in the interstitial fluid under the skin. This technology has the potential to significantly improve diagnosis and personalized treatment for conditions like diabetes and cardiovascular diseases.
Project team: Prof. Lilian Witthauer, Dr. Emmanouil Rousakis
Funding: Swiss National Science Foundation
More recent projects
The Moonwalk Project
Investigating the relationship between glucose values and motion patterns during sleepGlucose Levels and Sleep...
Volatile Organic Compounds in Breath
Volatile organic compounds and breath analysis in people with diabetesBreath analysis in individuals with diabetesThe...
Menstrual Cycle Study: Identifying changes in insulin sensitivity across the menstrual cycle in T1D
DCB and Tidepool are entering a partnership to explore the relationship between diabetes and women’s health. The first...
DCB Research AG
Freiburgstrasse 3
3010 Bern
Switzerland